Anti-retroviral therapy for HIV-infected children--toward maximal effectiveness

A J Melvin1

  • 1University of Washington, Seattle, USA.

Insights

Achieving viral suppression in children with HIV can be challenging. However, proper combination anti-retroviral therapy, adherence monitoring, and response tracking enable sustained benefits for pediatric HIV patients.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Immunology

Background:

  • HIV infection in children presents unique challenges for viral suppression compared to adults.
  • Combination anti-retroviral therapy (cART) is the standard of care for managing HIV in pediatric populations.
  • Long-term management requires careful consideration of adherence and treatment efficacy.

Purpose of the Study:

  • To evaluate the feasibility and effectiveness of cART in achieving sustained viral suppression in children with HIV.
  • To identify key factors influencing treatment outcomes in pediatric HIV management.
  • To underscore the importance of monitoring adherence and virologic response.

Main Methods:

  • Review of existing literature on pediatric HIV treatment regimens.
  • Analysis of data on adherence rates and virologic outcomes in children undergoing cART.
  • Comparison of treatment challenges and successes between pediatric and adult HIV patients.

Main Results:

  • Viral suppression can be more difficult to achieve in children than in adults.
  • Appropriate cART regimens at adequate dosages are crucial for pediatric patients.
  • Consistent monitoring of adherence and virologic response is essential for sustained benefit.

Conclusions:

  • Sustained benefit from cART in children with HIV is achievable with appropriate therapeutic strategies.
  • Effective management hinges on tailored regimens, adequate dosing, and diligent monitoring.
  • Pediatric HIV care requires a comprehensive approach to ensure long-term treatment success.

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...